BE713764A - - Google Patents

Info

Publication number
BE713764A
BE713764A BE713764DA BE713764A BE 713764 A BE713764 A BE 713764A BE 713764D A BE713764D A BE 713764DA BE 713764 A BE713764 A BE 713764A
Authority
BE
Belgium
Application number
Inventor
Edward Shanbrom
Original Assignee
Baxter Travenol Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24545372&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BE713764(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter Travenol Lab filed Critical Baxter Travenol Lab
Publication of BE713764A publication Critical patent/BE713764A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
BE713764D 1967-05-01 1968-04-17 BE713764A (hr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63483967A 1967-05-01 1967-05-01

Publications (1)

Publication Number Publication Date
BE713764A true BE713764A (hr) 1968-09-16

Family

ID=24545372

Family Applications (1)

Application Number Title Priority Date Filing Date
BE713764D BE713764A (hr) 1967-05-01 1968-04-17

Country Status (10)

Country Link
JP (1) JPS594402B1 (hr)
BE (1) BE713764A (hr)
DE (1) DE1767285C3 (hr)
DK (1) DK119626B (hr)
ES (1) ES353435A1 (hr)
FR (1) FR1589414A (hr)
GB (1) GB1178958A (hr)
IT (1) IT1048951B (hr)
NL (1) NL162838C (hr)
SE (1) SE375008B (hr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0022052A2 (en) * 1979-06-19 1981-01-07 David Amrani Process for the separation and isolation of the AHF fraction, the fibronectin fraction and the Von Willebrand's ristocetin cofactor fraction from blood plasma

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE348942B (hr) * 1970-06-02 1972-09-18 Statens Bakteriologiska Labor
US3803115A (en) 1972-05-17 1974-04-09 Baxter Laboratories Inc Stabilization of ahf using heparin
DE2550011C2 (de) * 1975-11-07 1982-11-25 Behringwerke Ag, 3550 Marburg Verfahren zur Herstellung eines antihämophilen Mittels
FR2460305A2 (fr) * 1979-06-29 1981-01-23 Merieux Inst Procede de preparation d'un concentre de facteur viii
DE3163003D1 (en) * 1980-01-18 1984-05-17 Canadian Red Cross Method of obtaining factor viii
DE3318521A1 (de) * 1983-05-20 1984-11-22 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Verfahren zur herstellung eines antihaemophiliefaktor-konzentrats
CA1293941C (en) * 1985-11-08 1992-01-07 Maria Erlinda Co-Sarno Method for preparing antihemophilic factor (ahf) by cold precipitation and for improving solubility of recovered ahf product
ATE85221T1 (de) 1988-11-05 1993-02-15 Octapharma Ag Verfahren zur herstellung eines hochreinen, nicht infektioesen antihaemophiliefaktors mittels chromatographie.
DE3926034C3 (de) * 1989-08-07 1996-11-21 Behringwerke Ag Verfahren zur Herstellung eines stabilen Faktors VIII

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL286954A (hr) * 1962-01-03

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0022052A2 (en) * 1979-06-19 1981-01-07 David Amrani Process for the separation and isolation of the AHF fraction, the fibronectin fraction and the Von Willebrand's ristocetin cofactor fraction from blood plasma
EP0022052A3 (en) * 1979-06-19 1981-11-11 David Amrani Process for the separation and isolation of the ahf fraction, the fibronectin fraction and the von willebrand's ristocetin cofactor fraction from blood plasma

Also Published As

Publication number Publication date
IT1048951B (it) 1980-12-20
GB1178958A (en) 1970-01-28
DK119626B (da) 1971-02-01
FR1589414A (hr) 1970-03-31
JPS594402B1 (hr) 1984-01-30
DE1767285B2 (de) 1980-12-04
DE1767285A1 (de) 1971-08-19
NL162838B (nl) 1980-02-15
SE375008B (hr) 1975-04-07
ES353435A1 (es) 1969-09-16
DE1767285C3 (de) 1981-08-20
NL162838C (nl) 1980-07-15
NL6806162A (hr) 1968-11-04

Similar Documents

Publication Publication Date Title
AU5765369A (hr)
FR1589414A (hr)
AU610966A (hr)
BE614676A (hr)
BE692198A (hr)
BE710980A (hr)
BE710979A (hr)
BE710752A (hr)
BE710399A (hr)
BE710395A (hr)
BE710367A (hr)
BE710324A (hr)
BE709394A (hr)
BE709075A (hr)
AU23366A (hr)
BE708205A (hr)
BE702408A (hr)
BE700656A (hr)
BE698676A (hr)
BE692922A (hr)
BE692780A (hr)
BE692779A (hr)
BE692778A (hr)
BE692654A (hr)
BE692577A (hr)

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: BAXTER LABORATORIES INC.

Effective date: 19850417